Slide
Session 64: Metabolic Complications of HIV-1 Disease
538 Prevalence
of Lipodystrophy and Metabolic Abnormalities in the Multicenter AIDS Cohort
Study (MACS).
539 Assessment
of Lipodystrophy in Patients Previously Exposed to AZT, ddI or ddC, but Naive
for d4T and Protease Inhibitors (PI), and Randomized Between d4T/3TC/ Indinavir
and AZT/3TC/Indinavir (NOVAVIR Trial).
540 A Randomised,
Double-Blind Study of Gemfibrozil (GF) for the Treatment of Protease Inhibitor-Associated
Hypertriglyceridaemia.
541 Indinavir
Inhibits Bone Formation while Ritonavir Inhibits Osteoclast Differentiation
and Function.